Invertebrates: a Source of Antiviral and Anticancer Drugs — How Reef Sponges, Snails and Sea Squirts Became Medicine
Several important drugs began with marine invertebrates. In the 1950s, unusual nucleosides found in the Caribbean reef sponge Tectitethya crypta inspired cytarabine (ara-C), a leukemia chemotherapy approved in the United States in 1969, and vidarabine (ara-A), an antiviral approved in 1976 for herpes-family infections. Since then, a cone snail’s venom has given the painkiller ziconotide, a sea squirt has given the cancer drug trabectedin, and a Japanese sponge inspired the breast-cancer drug eribulin. Because sponges, corals and sea squirts cannot run from danger, they defend themselves with powerful chemistry, and most species have never been screened for medical use.
Some of modern medicine’s most important drugs trace back to animals most people would walk straight past on a reef: a drab sponge, a slow-moving snail, a lumpy sea squirt. Marine invertebrates are among the richest sources of new chemistry on Earth, and the story of how they became antiviral and anticancer drugs is one of the best arguments for protecting coral reef biodiversity. This guide explains which medicines came from invertebrates, how a sponge helped launch an entire class of antiviral drugs, why reef animals make such potent molecules, and why losing reefs means losing medicines we have not yet found.
The reef sponge that changed medicine
The story of marine drugs begins in the 1950s with a sand-coloured sponge from shallow Caribbean waters.
In the early 1950s, the American chemist Werner Bergmann studied the reef sponge now called Tectitethya crypta (then known as Cryptotethya crypta). Inside it he found two unusual molecules, spongothymidine and spongouridine. They were nucleosides, the building blocks of DNA and RNA, but they were built around an unusual sugar, arabinose, instead of the ribose or deoxyribose found in ordinary genetic material.
That small difference turned out to matter enormously. A molecule that looks almost like a normal DNA building block can be taken up by a cell or virus that is copying its genes, and then jam the copying machinery. Chemists used Bergmann’s sponge nucleosides as a template to make synthetic arabinose nucleosides, and two of them became drugs.
- Cytarabine (ara-C) was approved in the United States in 1969 as a chemotherapy drug. It is still a standard treatment for acute myeloid leukemia and is used against some lymphomas.
- Vidarabine (ara-A) was approved in 1976 as an antiviral. It was used against herpes simplex and varicella-zoster (chickenpox and shingles) infections, including dangerous herpes infections of the brain. Newer drugs such as acyclovir later replaced it for most uses, but it was one of the first effective antiviral drugs of its kind.
These were among the first medicines to come out of marine natural-product chemistry, and the idea they demonstrated, that a modified nucleoside can stop viruses or cancer cells from copying themselves, became a cornerstone of later antiviral drug design. Many modern antiviral drugs are nucleoside analogues built on the same broad principle.

Why reef invertebrates are such good chemists
Animals that cannot run or hide have to fight with chemistry instead.
Sponges, corals, sea squirts and many other reef invertebrates are sessile, fixed to one spot for their adult lives, and most are soft-bodied. They cannot escape predators, swim away from disease or push back a neighbour trying to overgrow them. Over hundreds of millions of years, many of them evolved a different defence: they make toxic, bad-tasting or growth-blocking molecules.
A coral reef is one of the most crowded habitats on the planet. Every patch of hard surface is fought over, predators are everywhere and microbes are constantly trying to colonise living tissue. That intense competition has driven the evolution of an extraordinary variety of compounds: antibiotics to fight infection, toxins to deter fish, and molecules that stop nearby cells from dividing. Those last two jobs, killing cells and blocking cell division, are exactly what cancer drugs need to do, which is why so many marine compounds have been tested as anticancer agents.
Sponges are especially productive. Many host dense communities of bacteria and other microbes inside their tissues, and some of the most interesting “sponge” molecules are now thought to be made, at least in part, by these microbial partners. With thousands of species described and many more still unnamed, sponges remain one of the most promising groups in marine drug discovery.
Marine chemists often follow a simple rule of thumb: if no fish will eat a soft, exposed animal, it is probably protecting itself with something potent. Potency is exactly what drug developers are looking for.
Beyond sponges: cone snails, sea squirts and sea hares
Sponges started the field, but other invertebrates have since produced approved medicines of their own.
- Ziconotide (cone snail): predatory cone snails hunt with a harpoon-like tooth loaded with venom containing many different small peptides, called conotoxins, that target nerve channels. A synthetic version of one peptide from Conus magus, the magician’s cone, became ziconotide, a non-opioid painkiller given directly into the spinal fluid for severe chronic pain.
- Trabectedin (sea squirt): the Caribbean mangrove tunicate Ecteinascidia turbinata produces a complex alkaloid that damages the DNA of dividing cells. It was developed into trabectedin, used against certain soft-tissue sarcomas and ovarian cancer. A related compound, lurbinectedin, is used for some lung cancers. Learn more about these animals in reef tunicates.
- Eribulin (sponge): halichondrin B, a molecule from the Japanese sponge Halichondria okadai, blocks the cell’s internal scaffolding during division. A simplified, fully synthetic version, eribulin, is used for advanced breast cancer.
- Antibody–drug conjugates (sea hare): dolastatins, potent molecules first found in the sea hare Dolabella auricularia and now known to come from cyanobacteria in its diet, inspired the toxic “payload” used in several targeted cancer drugs.
Marine invertebrates also help medicine in less obvious ways. Blood from the Atlantic horseshoe crab, an arthropod, is used to make a test that detects bacterial toxins in injectable drugs and medical devices, and that test has been part of pharmaceutical safety checks for decades.
How marine drug discovery works today
Turning a reef animal’s defence into a medicine takes many years and a long chain of science.
The process usually starts with collection. Scientists gather small samples of invertebrates, often by scuba or remotely operated vehicles in deeper water, and extract their chemicals. The extracts are screened against cancer cells, viruses, bacteria or specific drug targets. When an extract shows activity, chemists isolate the responsible molecule, work out its structure and test how it works.
Most candidates fail. A molecule may be too toxic, too unstable or impossible to make in quantity. The few that succeed go through laboratory and animal studies, then several phases of human clinical trials before a regulator approves them. The journey from discovery to pharmacy can take decades, which is why the handful of approved marine drugs represents a far larger body of research behind the scenes.
Modern tools are speeding things up. Genetic sequencing lets researchers find the genes that make a compound, sometimes inside a sponge’s microbes, and transfer them into lab-grown organisms. Advances in chemical synthesis now allow even very complex marine molecules to be built from scratch. These approaches reduce pressure on wild reefs while keeping the reef’s chemistry accessible to science.
Antiviral research and the reef
The sponge nucleosides were an antiviral breakthrough, and marine invertebrates are still being studied for new antivirals.
Viruses are hard to treat because they use the host’s own cell machinery to reproduce. A good antiviral has to block a step that the virus depends on without harming the patient’s cells too much. Nucleoside analogues like vidarabine do this by targeting the enzymes that copy viral DNA. That strategy, first shown with sponge-inspired molecules, is now used against many viruses, from herpes to HIV and hepatitis.
Researchers continue to screen sponges, soft corals, sea squirts and other invertebrates for compounds that interfere with viral entry, replication or assembly. Many marine extracts show antiviral activity in the laboratory. Only a small fraction will ever become medicines, but each new class of molecule gives scientists fresh ideas about how to attack viruses, including ones that have become resistant to existing drugs.
Losing the reef means losing its medicines
Every reef species lost before it is studied could take an undiscovered medicine with it.
Only a small fraction of reef invertebrates has ever been chemically examined, and many species have not even been formally described. When reefs decline through coral bleaching, pollution, destructive fishing or coastal development, their sponges, sea squirts and other invertebrates go with them. Once a species is gone, its unique chemistry is gone too, along with any drug it might have inspired.
That gives coral reef conservation a direct human stake beyond fisheries and tourism. Protecting reef biodiversity also protects a living library of molecules shaped by hundreds of millions of years of evolution. Responsible bioprospecting, with fair benefit-sharing for the countries whose reefs provide the samples and careful limits on collection, is part of that picture.
To explore the animals behind this chemistry, start with our guides to coral reef sponges, tunicates and the wider world of coral reef invertebrates, which make up the vast majority of animal species on Earth, as explained in invertebrates account for about 97 percent of known species.
Related on TheSea
- Invertebrates Eat Anything Alive or Dead
- A Lobster’s Teeth Are in Its Stomach
- Coral Reef Annelids
- Hermit Crab Habitat
- Platyhelminthes
- All Crustaceans Have an Exoskeleton
- Crabs Hatch as Tiny Larvae, Not Miniature Crabs
- Crabs Have Large Compound Eyes on Stalks
- Starfish Regenerate Missing Parts of Their Body
- Lobsters Can Live as Long as 100 Years
- The Crab Life Cycle
- Japanese Spider Crab
Which drugs come from marine invertebrates?
Well-known examples include cytarabine and vidarabine (inspired by a Caribbean reef sponge), ziconotide (from cone snail venom), trabectedin (from a sea squirt) and eribulin (based on a molecule from a Japanese sponge).
What antiviral drug came from a sponge?
Vidarabine (ara-A). It was developed from unusual arabinose nucleosides found in the sponge Tectitethya crypta and was approved in 1976 to treat herpes simplex and varicella-zoster virus infections.
Is cytarabine made from a sponge?
Cytarabine is made synthetically today, but it was modelled on nucleosides first found in a Caribbean reef sponge in the 1950s. It is still widely used to treat acute myeloid leukemia.
Why do sponges and other invertebrates make medicinal chemicals?
Most are fixed in place and soft-bodied, so they defend themselves chemically against predators, infection and competitors. Many of these defensive molecules kill cells or block cell division, which is useful in cancer and antiviral treatment.
What drug comes from cone snails?
Ziconotide, a synthetic version of a peptide from the venom of the magician’s cone, Conus magus. It is a non-opioid painkiller for severe chronic pain, delivered directly into the spinal fluid.
Are there more medicines left to find on coral reefs?
Very likely. Only a small fraction of reef invertebrates has been chemically screened, and new marine compounds are described every year. Many are being tested against cancer, viruses, bacteria and pain.
- Bergmann, W. & Feeney, R.J. (1950s), papers on nucleosides of the sponge Cryptotethya crypta, Journal of Organic Chemistry
- U.S. National Library of Medicine / NIH: drug monographs for cytarabine, vidarabine, ziconotide, trabectedin and eribulin
- Mayer, A.M.S. et al., marine pharmacology reviews and the global marine pharmaceutical pipeline
- Frontiers in Pharmacology: reviews of marine-derived nucleosides and antiviral drug development
Blane Perun has been exploring Earth’s oceans and marine life for over 25 years. Founder of TheSea.Org in 1999, underwater photographer, coral aquaculture pioneer, and explorer of 80+ countries.
About Blane Perun → More on Coral Reef Invertebrate →